LexOrbis is a premier full-service IP law firm with 270 personnel including 130+ attorneys at its three offices in India namely, New Delhi, Bangalore and Mumbai. The firm provides business oriented and cost-effective solutions for protection, enforcement, transaction, and commercialization of all forms of intellectual property in India and globally. The Firm has been consistently ranked amongst the Top- 5 IP firms in India for over the past one decade and is well-known for managing global patent, designs and trademark portfolios of many technology companies and brand owners.
Bio-printing refers to the 3D printing technology for printing living tissues, growing new organs, and specially growing a human kidney instead of harvesting or transplanting.
DPS Parmar’s articles from LexOrbis are most popular:
within Intellectual Property topic(s)
in United States
with readers working within the Pharmaceuticals & BioTech industries
LexOrbis are most popular:
within Finance and Banking, Antitrust/Competition Law and Employment and HR topic(s)
Bio-printing refers to the 3D printing technology for printing
living tissues, growing new organs, and specially growing a human
kidney instead of harvesting or transplanting. With this technique
it is now possible to grow other human organs like muscles, blood
vessels, bladders, and so on. However, when we talk about
relationship between 3D bio-printing and patent rights in India, it
might just become another complex issue where technology and
morality collides.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.